| Title |
Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma
|
|---|---|
| Published in |
Journal of Hematology & Oncology, September 2019
|
| DOI | 10.1186/s13045-019-0786-6 |
| Pubmed ID | |
| Authors |
Bo Yu, Delong Liu |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 90 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 11% |
| Student > Bachelor | 10 | 11% |
| Researcher | 10 | 11% |
| Student > Master | 7 | 8% |
| Other | 6 | 7% |
| Other | 11 | 12% |
| Unknown | 36 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 15 | 17% |
| Medicine and Dentistry | 11 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 8% |
| Chemistry | 3 | 3% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 10 | 11% |
| Unknown | 42 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2024.
All research outputs
#8,049,150
of 25,613,746 outputs
Outputs from Journal of Hematology & Oncology
#586
of 1,299 outputs
Outputs of similar age
#132,436
of 352,364 outputs
Outputs of similar age from Journal of Hematology & Oncology
#10
of 21 outputs
Altmetric has tracked 25,613,746 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 1,299 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,364 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.